Activity of ceftobiprole against Pseudomonas aeruginosa clinical isolates from Europe collected in 2005-2006

被引：0

|

作者：

Davies, T.

Sahm, D.

Flamm, R.

Bush, K.

机构：

来源：

INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS | 2007年 / 29卷

关键词：

D O I：

暂无

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

引用

收藏

页码：S583 / S583

页数：1

相关论文

共 50 条

[1] Baseline activity of ceftobiprole against methicillin-susceptible and -resistant staphylococcal clinical isolates from Europe collected in 2005-2006
Davies, T.
Sahm, D.
Flamm, R.
Bush, K.
[J]. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2007, 29 : S172 - S172
[2] Activity of ceftobiprole tested against contemporary European Enterobacteriaceae and Pseudomonas aeruginosa (2005-2006)
Fritsche, T.
Sader, H.
Strabala, P.
Jones, R.
[J]. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2007, 29 : S195 - S195
[3] Activity of ceftobiprole tested against staphylococcal and streptococcal isolates recovered from patients in European medical centres (2005-2006)
Fritsche, T.
Sader, H.
Strabala, P.
Jones, R.
[J]. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2007, 29 : S195 - S195
[4] Antimicrobial Activity of Murepavadin Tested against Clinical Isolates of Pseudomonas aeruginosa from the United States, Europe, and China
Sader, Helio S.
Dale, Glenn E.
Rhomberg, Paul R.
Flamm, Robert K.
[J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2018, 62 (07)
[5] Profile of ceftobiprole activity against S-aureus, S-pneumoniae, Enterobacteriaceae, and P-aeruginosa:: results of the 2005-2006 Surveillance Program
Aranza, M. K.
Draghi, D. C.
Jones, M. E.
Thornsberry, C.
Sahm, D. F.
[J]. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2007, 29 : S582 - S583
[6] In vitro activity of ceftobiprole against Acinetobacter baumannii clinical isolates
Marti, Sara
Sanchez-Cespedes, Javier
Espinal, Paula
Vila, Jordi
[J]. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2009, 34 (03) : 265 - 267
[7] In vitro activity of meropenem in combination with ciprofloxacin against clinical isolates of Pseudomonas aeruginosa
Solak, S
Willke, A
Ergönül, Ö
Tekeli, E
[J]. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2005, 25 (02) : 181 - 182
[8] In vitro activity of ceftobiprole against clinical isolates of Pseudomonas aeruginosa obtained from Canadian intensive care unit (ICU) patients as part of the CAN-ICU Study
Walkty, Andrew
DeCorby, Melanie
Nichol, Kim
Karlowsky, James A.
Hoban, Daryl J.
Zhanel, George G.
[J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2008, 62 (01) : 206 - 208
[9] In vitro activity of ceftaroline, ceftobiprole and cethromycin against clinical isolates of Streptococcus pneumoniae collected from across Canada between 2003 and 2008
Patel, Samir N.
Pillai, Dylan R.
Pong-Porter, Sylvia
McGeer, Allison
Green, Karen
Low, Donald E.
[J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2009, 64 (03) : 659 - 660
[10] PYOCIN ACTIVITY IN CLINICAL ISOLATES OF PSEUDOMONAS-AERUGINOSA
GOLDSCHMIDT, E
SCHREIBMAN, E
MERZBACH, D
[J]. ISRAEL JOURNAL OF MEDICAL SCIENCES, 1983, 19 (07): : 671 - 671

← 1 2 3 4 5 →